Objective: The objective of the current study was to find a metabolic signature associated with the early manifestations of type-2 diabetes mellitus.
Research Design And Method: Modern metabolic profiling technology (MxP™ Broad Profiling) was applied to find early alterations in the plasma metabolome of type-2 diabetic patients. The results were validated in an independent study.